(1)
Aslonov I.F. IMPACT OF COMORBID CONDITIONS ON THE DEVELOPMENT OF NEPHROTOXICITY IN PATIENTS RECEIVING ANTI-TUBERCULOSIS THERAPY. CAJM 2026, 1 (11), 240-245.